Print

Print


Study: Destructiveness of MS cuts nerves in two
Damage more extensive than previously thought

January 28, 1998

BOSTON (CNN) -- New evidence shows that multiple sclerosis, a neurological
disease that affects more than 300,000 Americans, may be more destructive to
nerve cells that previously thought.

According to a study in the latest issue of the New England Journal of
Medicine, researchers at The Cleveland Clinic discovered that in some MS
patients, axons -- the long fibers on nerve cells that allow for
transmission of electrical impulses through the body -- are severed. Such
damage is permanent and irreversible, the researchers said.

Until now, the conventional wisdom was that MS stripped away the myelin, or
outside covering, of nerve cells in the brain and spine -- and that those
cells could compensate for the loss. Scientists believed that was why many
MS patients seemed to get better for a time before beginning another
downhill slide.

But by examining the autopsied brains of 11 MS patients and four who did
not, researchers concluded that MS not only damages the myelin but cuts the
axons. That may explain why some patients steadily decline, rather that
deteriorating in spurts.

However, due to the small number of patients in the Cleveland study,
researchers said they were unable to determine how common severing of the
axons is among MS patients at large.

Though the new discovery indicates that the damage wrought by MS may be
worse than previously thought, experts say the breakthrough may actually
lead to the development of new treatments for MS.

"I think there's hope that neuro-protective therapies that are being
developed for other neuro-degenerative disease, such as Alzheimer's disease,
PARKINSON'S disease and ALS, may prove fruitful as therapeutics in multiple
sclerosis," said Bruce Trapp of The Cleveland Clinic.

The new information also led researchers to the conclusion that damage to
nerve cells in people with MS might begin even before they notice any
symptoms. So the research raises the possibility that patients ought to
begin treatment very early in the course of the disease.

Judith Richards
[log in to unmask]